(Q102060085)

English

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

scientific article published on 12 November 2020

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from abstract

Stephen T. Holgate

9

object named as

Stephen T Holgate

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

author name string

Phillip D Monk

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Richard J Marsden

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Victoria J Tear

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Jody Brookes

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Toby N Batten

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Marcin Mankowski

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Felicity J Gabbay

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Donna E Davies

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Ling-Pei Ho

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Tristan Clark

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Ratko Djukanovic

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Tom M A Wilkinson

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Inhaled Interferon Beta COVID-19 Study Group

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

publication date

12 November 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

The Lancet. Respiratory medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33189161%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Clinical Characteristics of Coronavirus Disease 2019 in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating the burden of SARS-CoV-2 in France

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Remdesivir for the Treatment of Covid-19 — Final Report

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms and implications of age-associated impaired innate interferon secretion by dendritic cells: a mini-review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral immunity is impaired in COPD patients with frequent exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral activities of type I interferons to SARS-CoV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of SARS with human interferons

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) Study: Rationale and Design

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Type 1 interferons as a potential treatment against COVID-19

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2820%2930511-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q102060085&oldid=1645904760"